Molecular Diagnostics Market by Application (Infectious Disease, Oncology, Genetics, Microbiology), Technology (PCR, INAAT, DNA Sequencing), End User (Hospital, Laboratories), Product (Instruments, Reagent, Service, Software) - Global Forecasts to 2018

Published: June 2014
No. of Pages: 300
  

Rising Prevalence of Major Infectious Diseases, Introduction of Reagents (Molecular Assays), and Technological Advancements (PCR, INAAT, and Microarray) Are Likely to Drive the Molecular Diagnostics Market in the Next Five Years

Molecular diagnostics (MDx) has emerged as one of the largest and fastest growing segments in the In vitro Diagnostic (IVD) industry. In the span of few years, molecular diagnostics has prospered from a non-existent market to a significant market. PCR tests such as the one from Roche for CT/NG and other tests such as HIV qualitative and HIV quantitative (viral load) are the key factors driving the expansion of the molecular diagnostics market. The private reference laboratories developed tests for infectious diseases and cancer mutations due to the rising incidences and the non-availability of FDA approved assays. The market began to expand due to the existence of different diagnostic kits for genetic diseases and the blood screening for various infectious diseases. The demand for molecular testing increased and the FDA approved molecular diagnostic tests for determining genetic variation responses against cancer drugs. As a result, molecular diagnostic testing is growing at a rapid rate due to the rising adoption of rapid and quick diagnosis.

The reagents product segment accounted for the largest share of the total molecular diagnostics market in 2013 and will continue to grow in the next five years to retain its leading position. The high growth in this segment is attributed to the growing demand for molecular assays. Moreover, the rising incidences of infectious diseases such as HBV, HIV, CT/NG, and MRSA have also contributed to the largest share of the reagents market. The hospitals end user segment accounted for the second largest share in 2013. This segment can monitor various physiological parameters of a patient in order to have an overview of the patients’ health and status. Due to the tremendous increase in the number of infectious diseases, hospitals are increasing their investments in molecular diagnostic testing.

The PCR technology segment, on the other hand, will be the fastest growing segment in the coming years due to the evolution in technology that helps in diagnosis of various diseases. With the growing incidences and increasing awareness of various diseases this market is set to grow at a faster pace. Under this segment, the INAAT segment is also expected to grow at a higher pace in the forecast period. The microarray technology is also expected to be among the fastest growing in all other segments of the molecular diagnostics market.

In 2013, North America accounted for the largest share and will retain its leading position by 2018. This growth is attributed to the increasing prevalence of lifestyle diseases and spread of various contagious diseases. Asia is the most lucrative region for molecular diagnostics in the next five years, and is poised to grow at a CAGR of 12.2% in the forecast period. The high population base and the improved purchasing power of patients will drive this market. Moreover, the economic crisis in western countries has propelled the companies to focus on the Asian region, thus leading to the economic growth and rise in the investments in this region, which is further driving the market in a positive direction.
The grey area while estimating the market size was the overlapping nature of the applications segment and while segregating them based on the evaluation of endpoints involved. This was later clarified with the help of various experts that participated in the study.

From an insight perspective, this research report focuses on the qualitative data; market size, share, and growth of various segments and sub-segments; competitive landscape; and company profiles. The qualitative data covers various levels of industry analysis, such as market dynamics (drivers, restraints, opportunities, and threats) and technological trends, globally. It also focuses on the emerging and high-growth segments of the molecular diagnostics market and the initiatives of their respective governments.

The competitive landscape covers the growth strategies adopted by the industry players in the last three years. The company profiles comprises of the basic views on the key players in the molecular diagnostics market and their product portfolios, developments, and strategies adopted to maintain and increase their market share in the near future.

The above mentioned market research data, current market size, and forecast of the future trends will help the key players and new entrants to make necessary decisions regarding product offerings, geographic focus, change in strategic approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.

Molecular Diagnostics Market by Application (Infectious Disease, Oncology, Genetics, Microbiology), Technology (PCR, INAAT, DNA Sequencing), End User (Hospital, Laboratories), Product (Instruments, Reagent, Service, Software) - Global Forecasts to 2018

Table Of Contents

1 Introduction
1.1 Objectives of the Study
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Market Scope
1.6 Research Methodology
1.6.1 Market Size Estimation & Data Triangulation
1.6.2 Key Data From Secondary Sources
1.6.3 Key Data Points From Primary Sources
1.6.4 Assumptions

2 Executive Summary

3 Premium Insight

4 Market Overview
4.1 Introduction
4.2 Market Segmentation
4.3 Market Dynamics
4.3.1 Drivers
4.3.1.1 Increasing Awareness and Acceptance of Personalized Medicine and Companion Diagnostics
4.3.1.2 Development of Biomarker Identification and Advancements in Molecular Techniques
4.3.1.3 Proteomics and Genomics Technology Research to Goad the Molecular Testing Market
4.3.1.4 Increase in AGing Population to Spur Growth of the Molecular Diagnostics Market
4.3.1.5 Reformations in the Reimbursement System
4.3.2 Restraints
4.3.2.1 Increased Costs of Molecular Diagnostics tools With New and Complex Platforms Demand Skilled Labor and Mandatory Training
4.3.2.2 Reimbursement Issues
4.3.2.3 Complex Regulatory Framework to Delay Approvals of New Molecular Diagnostic Tests
4.3.3 Opportunities
4.3.3.1 Extending the Reach of Molecular Diagnostics
4.3.3.2 Emerging Technologies Can Soon Gain Importance in Molecular Diagnostic Tests
4.3.4 Threats
4.3.4.1 Lack of Budget and Labor
4.3.4.2 Stringent Regulatory Framework to Stifle the Growth of Mdx Market
4.4 Market Share Analysis
4.5 Molecular Diagnostic Laboratories and Tests
4.6 End-User Analysis
4.7 Effects of Obamacare on the Molecular Diagnostics Market

5 Global Molecular Diagnostics Market, By Application
5.1 Introduction
5.2 Infectious Diseases
5.2.1 Hepatitis B Virus (HBV)
5.2.2 Hepatitis C Virus (HCV)
5.2.3 Human Immunodeficiency Virus (HIV)
5.2.4 Tuberculosis (TB)
5.2.5 Chlamydia Trachomatis and Neisseria Gonorrhea (CT/NG)
5.2.6 Human Papillomavirus (HPV)
5.2.7 Methicillin-Resistant Staphylococcus Aureus (MRSA)
5.2.8 Others
5.3 oncology
5.3.1 Prostate Cancer
5.3.2 Breast Cancer
5.3.3 Colorectal Cancer
5.3.4 Others
5.4 Genetics
5.5 Blood Screening
5.6 Microbiology
5.7 Others

6 Global Molecular Diagnostics Market, By Technology
6.1 Introduction
6.2 Polymerase Chain Reaction (PCR)
6.3 Isothermal Nucleic Acid Amplification Technology (INAAT)
6.4 Microarrays
6.5 Hybridization (in Situ Hybridization and Fluorescence in Situ Hybridization)
6.6 Dna Sequencing & Next-Generation Sequencing
6.7 Others

7 Global Molecular Diagnostics Market, By Product Type
7.1 Introduction
7.2 Instruments
7.3 Reagents
7.4 Services & Software

8 Geographic Analysis
8.1 Introduction
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 U.K.
8.3.2 Germany
8.3.3 France
8.3.4 Italy
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia
8.4.1 Japan
8.4.2 India
8.4.3 China
8.4.4 Rest of Asia (ROA)
8.5 Rest of the World (ROW)
8.5.1 Latin America
8.5.2 Pacific
8.5.3 Middle East & Africa

9 Competitive Landscape
9.1 Introduction
9.2 New Product Launch
9.3 Mergers & Acquisitions
9.4 Agreement/Partnership/Collaboration
9.5 Expansion
9.6 Other Developments

10 Company Profiles (Overview, Financials, Products & Services, Strategy, & Developments)*
10.1 Abbott Diagnostics, Inc.
10.2 Beckman Coulter, Inc.
10.3 Becton, Dickinson & Co.
10.4 Biomérieux Business Overview
10.5 Cepheid, Inc.
10.6 Gen-Probe, Inc. (Hologic, Inc.)
10.7 Novartis AG
10.8 Qiagen
10.9 Roche Diagnostics
10.1 Siemens Healthcare

*Details on Financials, Product & Services, Strategy, & Developments Might Not Be Captured in Case of Unlisted Companies.

List of Tables

Table 1 Molecular Diagnostics Market, By Geography, 2011–2018 ($Million)
Table 2 Global Market, By Application, 2011–2018 ($Million)
Table 3 Total Number of Molecular Diagnostic Laboratories, By Region 2011-2018
Table 4 Total Number of Molecular Diagnostic Tests, By Region 2011-2018, (Millions)
Table 5 Global Molecular Diagnostics Market Size, By End User, 2011–2018 ($Million)
Table 6 Global Molecular Diagnostics Market Size, By Application, 2011–2018 ($Million)
Table 7 Global Infectious Diseases Molecular Diagnostics Market Size, By Type of Disease, 2011–2018 ($Million)
Table 8 Infectious Diseases Molecular Diagnostics Market Size, By Region, 2011–2018 ($Million)
Table 9 Global Oncology Molecular Diagnostics Market Size, By Type, 2011–2018 ($Million)
Table 10 Oncology Molecular Diagnostics Market Size, By Region, 2011–2018 ($Million)
Table 11 Genetics Molecular Diagnostics Market Size, By Region, 2011–2018 ($Million)
Table 12 Blood Screening Molecular Diagnostics Market Size, By Region, 2011–2018 ($Million)
Table 13 Microbiology Molecular Diagnostics Market Size, By Region, 2011–2018 ($Million)
Table 14 Other Molecular Diagnostics Market Size, By Region, 2011–2018 ($Million)
Table 15 Global Molecular Diagnostics Market Size, By Technology, 2011–2018 ($Million)
Table 16 PCR Technology Market Size, By Region, 2011–2018 ($Million)
Table 17 INAAT Market Size, By Region, 2011–2018 ($Million)
Table 18 Microarray Technology Market Size, By Region, 2011–2018 ($Million)
Table 19 Hybridization Technology Market Size, By Region, 2011–2018 ($Million)
Table 20 Dna Sequencing & Ngs Molecular Diagnostics Market Size, By Region, 2011–2018 ($Million)
Table 21 Other Molecular Diagnostics Technologies Market Size,By Region, 2011–2018 ($Million)
Table 22 Global Molecular Diagnostics Market Size, By Type of Product & Service, 2011–2018 ($Million)
Table 23 Molecular Diagnostics Instruments Market Size, By Region, 2011–2018 ($Million)
Table 24 Molecular Diagnostics Reagents Market Size, By Region, 2011–2018 ($Million)
Table 25 Molecular Diagnostics Services & Software Market Size, By Region, 2011–2018 ($Million)
Table 26 Molecular Diagnostics Market Size, By Geography, 2011–2018 ($Million)
Table 27 North America: Molecular Diagnostics Market Size, By Country, 2011–2018 ($Million)
Table 28 North America: Market Size, By Application, 2011–2018 ($Million)
Table 29 North America: Market Size, By Technology, 2011–2018 ($Million)
Table 30 North America: Market Size, By Type of Product & Service, 2011–2018 ($Million)
Table 31 U.S.: Molecular Diagnostics Market Size, By Application, 2011–2018 ($Million)
Table 32 U.S.: Market Size, By Technology, 2011–2018 ($Million)
Table 33 U.S.: Market Size, By Type of Product & Service, 2011–2018 ($Million)
Table 34 Canada: Market Size, By Application, 2011–2018 ($Million)
Table 35 Canada: Market Size, By Technology, 2011–2018 ($Million)
Table 36 Canada: Market Size, By Type of Product & Service, 2011–2018 ($Million)
Table 37 Europe: Market Size, By Country, 2011–2018 ($Million)
Table 38 Europe: Market Size, By Application, 2011–2018 ($Million)
Table 39 Europe: Market Size, By Technology, 2011–2018 ($Million)
Table 40 Europe: Market, By Type of Product & Service, 2011–2018 ($Million)
Table 41 U.K.: Market Size, By Application, 2011–2018 ($Million)
Table 42 U.K.: Market Size, By Technology, 2011–2018 ($Million)
Table 43 U.K.: Market Size, By Type of Product & Service, 2011–2018 ($Million)
Table 44 Germany: Market Size, By Application, 2011–2018 ($Million)
Table 45 Germany: Market Size, By Technology, 2011–2018 ($Million)
Table 46 Germany: Market, By Type of Product & Service, 2011–2018 ($Million)
Table 47 France: Market Size, By Application, 2011–2018 ($Million)
Table 48 France: Market Size, By Technology, 2011–2018 ($Million)
Table 49 France: Market Size, By Type of Product & Service, 2011–2018 ($Million)
Table 50 Italy: Market Size, By Application, 2011–2018 ($Million)
Table 51 Italy: Market Size, By Technology, 2011–2018 ($Million)
Table 52 Italy: Market Size, By Type of Product & Service, 2011–2018 ($Million)
Table 53 Spain: Market Size, By Application, 2011–2018 ($Million)
Table 54 Spain: Market Size, By Technology, 2011–2018 ($Million)
Table 55 Spain: Market Size, By Type of Product & Service, 2011–2018 ($Million)
Table 56 Rest of Europe: Market Size, By Application, 2011–2018 ($Million)
Table 57 Rest of Europe: Market Size, By Technology, 2011–2018 ($Million)
Table 58 Rest of Europe: Market Size, By Type of Product & Service, 2011–2018 ($Million)
Table 59 Asia: Market Size, By Region, 2011–2018 ($Million)
Table 60 Asia: Market Size, By Application, 2011–2018 ($Million)
Table 61 Asia: Market Size, By Technology, 2011–2018 ($Million)
Table 62 Asia: Market Size, By Type of Product & Service, 2011–2018 ($Million)
Table 63 Japan: Market Size, By Application, 2011–2018 ($Million)
Table 64 Japan: Market Size, By Technology, 2011–2018 ($Million)
Table 65 Japan: Market Size, By Product&Service Type, 2011–2018 ($Million)
Table 66 India: Market Size, By Application, 2011–2018 ($Million)
Table 67 India: Market Size, By Technology, 2011–2018 ($Million)
Table 68 India: Market Size, By Type of Product & Service, 2011–2018 ($Million)
Table 69 China: Market Size, By Application, 2011–2018 ($Million)
Table 70 China: Market Size, By Technology, 2011–2018 ($Million)
Table 71 China: Market Size, By Type of Product & Service, 2011–2018 ($Million)
Table 72 ROA: Molecular Diagnostics Market Size, By Application, 2011–2018 ($Million)
Table 73 ROA: Market Size, By Technology, 2011–2018 ($Million)
Table 74 ROA: Market Size, By Type of Product & Services, 2011–2018 ($Million)
Table 75 ROW: Market Size, By Region, 2011–2018 ($Million)
Table 76 ROW: Market Size, By Application, 2011–2018 ($Million)
Table 77 ROW: Market Size, By Technology, 2011–2018 ($Million)
Table 78 ROW: Market Size, By Type of Product & Service, 2011–2018 ($Million)
Table 79 Latin America: Market Size, By Application, 2011–2018 ($Million)
Table 80 Latin America: Market Size, By Technology, 2011–2018 ($Million)
Table 81 Latin America: Market Size, By Type of Product & Service, 2011–2018 ($Million)
Table 82 Pacific: Market Size, By Application, 2011–2018 ($Million)
Table 83 Pacific: Market Size, By Technology, 2011–2018 ($Million)
Table 84 Pacific: Market Size, By Type of Product & Service, 2011–2018 ($Million)
Table 85 Middle East & Africa: Molecular Diagnostics Market Size, By Application, 2011–2018 ($Million)
Table 86 Middle East & Africa: Market Size, By Technology, 2011–2018 ($Million)
Table 87 Middle East & Africa: Market Size, By Type of Product & Service, 2011–2018 ($Million)
Table 88 New Product Launch(2011-2014)
Table 89 Mergers & Acquisitions (2011-2014)
Table 90 Agreement/Partnership/Collaboration(2011-2014)
Table 91 Expansion(2011-2012)
Table 92 Other Developments(2011-2014)

List of Figures

Figure 1 Market Size Estimation and Data Triangulation
Figure 2 Forecast Model
Figure 3 Global Molecular Diagnostics Market, By Technology, 2013–2018 ($Million)
Figure 4 Global Moleculer Diagnostics Market, 2011-2018 ($Million)
Figure 5 Market Dynamics
Figure 6 Market Snapshot, 2013 ($Million)
Figure 7 Global Market Share Analysis, By Application, 2013 & 2018
Figure 8 Opportunity Matrix, Global Market Size, By Technology, 2013
Figure 9 Global Market, By End-User, 2013 & 2018 ($Million)
Figure 10 Global Market Share Analysis, By Product 2013
Figure 11 Global Molecular Diagnostics Market
Figure 12 Global Market, Share Analysis, 2013
Figure 13 Global Market, By End User, 2013 ($Million)
Figure 14 Opportunity Matrix, Global Market, By Application, 2013
Figure 15 Global Market Share Analysis, By Technology (2013 & 2018)
Figure 16 Global Market Size, By Product, 2018 ($Million)
Figure 17 Molecular Diagnostics Market, Geographic Analysis, By Application 2013 ($Million)
Figure 18 Key Growth Strategies, Molecular Diagnostics Market, 2011–2018

Published By: MarketsandMarkets
Product Code: MarketsandMarkets1922


Did you find what you are/were looking for ? If not, read below and browse through other relevant pages for similar market research reports OR get in touch with us through the form/contact info in your right navigation panel and we’ll share relevant market report titles for you to explore.

Related Reports:


Why ReportsnReports.com?

  • 400,000 market research reports and growing.
  • Top Fortune 500 Organizations trust us for research data.
  • 24/7 support on call as well as emails.
  • Your Details are safe with us.
  • Free support for your research requirements.
  • Report Delivery: Email
  • Delivery Time:
    • Upto 24 hrs - working days
    • Upto 48 hrs max - weekends and public holidays

Research Support / Custom Research

If this business study does not have the data and information analysis you need, contact us with your research requirements. We explore available market research reports to map your needs and share report titles with you. Alternatively, we can also offer custom research that suits your budget and timelines. Share your information requirements here.
Connect With Us
Email: sales@reportsandreports.com Call : + 1 888 391 5441

Subscription Option

Using our subscription option, you get access to market research reports and industry data of Healthcare market as per your needs. Get the best of Healthcare research reports by utilizing your research budgets in an optimum way.

More about our Subscription option
Email Alerts

Get Email alerts about market research reports from industries and publishers of your interest:

Live Chat
Live Chat by Comm100